Canna Pharms Clinic
Cannabis Oil Info
Canna-Pharms Custom Oil
Custom Oil For Humans
Custom Oil For Pets
Cannabinoid Therapy
ALS (Lou Gehrig's) Treatment
Rheumatoid Arthritis
Chronic Pain
Pain Management
Anxiety and Depression
Cancer
Gastrointestinal Disorders
Irritable Bowel Syndrome (IBS)
Stroke
Epilepsy
Aphasia
PTSD
Diabetes
Covid-19
Lyme Disease
Insomnia
Consultations
Contact Us
Physicians
ALS Treatment
ALS exercise routine
ALS Toxins List
ALS diet recommendations
ALS Program Intake Form 1
Our Story
Our Research Paper
Client Reviews
Dispensary
Our Research Papers
Remission, Reversal, Cure, and the Potential of Cannabinoid Therapy in Amyotrophic Lateral Sclerosis (ALS)
Apr 9, 2025, 9:39 PM
The Imperfect Harmony: Why Off-the-Shelf Hemp Oil Falls Short in Targeted Cannabinoid Therapy
Apr 2, 2025, 3:08 AM
The Right to Choose: Exploring Access to Unconventional Treatments in the Face of Terminal Illness
Mar 29, 2025, 5:09 PM
Customized Cannabinoid Oil: A Logical Solution for Treating Illnesses
Mar 28, 2025, 8:26 PM
Balancing the endocannabinoid system (ECS)
Mar 27, 2025, 10:25 PM
The Endocannabinoid System: A Therapeutic Target for a Spectrum of Illnesses
Mar 24, 2025, 10:38 PM
Cannabinoid Therapy as a Potential Modulator of ATXN2 Mutation-Induced TDP-43 Misfolding
Mar 24, 2025, 2:11 PM
The Endocannabinoid System's Role in Modulating Amyotrophic Lateral Sclerosis Symptoms: A Focus on the Entourage Effect and Targeted Cannabinoid Therapies
Mar 21, 2025, 10:53 AM
The Delayed Dawn of Terpene Therapeutics: Unraveling the Roots of Slow Recognition
Mar 20, 2025, 9:35 PM
The Gut-Brain Axis and Amyotrophic Lateral Sclerosis: Exploring the Impact of Gut Health on Disease Pathogenesis
Mar 20, 2025, 2:08 PM
← Previous
1
(current)
2
Next →